Global Oxiracetam Market Size, Share and Trends Analysis Report, By Product Type (Powder and Capsule), By Application (Alzheimer’s disease, Dementia, and Other), Forecast Period (2022-2028)

The global oxiracetam market is anticipated to grow at a CAGR of 4.2% during the forecast period (2022-2028). The racetam family of nootropics includes oxiracetam. It is one of the most well-known and widely used nootropics. It has a modest stimulating effect and is used to treat cognitive deficiencies caused by cerebrovascular disease. The ability of the nootropic medication to improve mental vigor, intellect, and memory is well-known. It’s offered as a powder or as a capsule. The injection form is commonly used for stroke patients with memory problems, whereas the oral form is utilized for Alzheimer’s patients. Oxiracetam (ISF 2522) is a nootropic medication that improves memory and learning.
The oxiracetam market is expected to increase in response to rising demand for brain boosters and rising consumer awareness about brain health. The market is expected to rise due to the rising frequency of Alzheimer’s disease, dementia, and other neurological issues. The demand for oxiracetam is fueled by factors such as an aging population, alcohol and drug misuse, and other trauma that causes short-term memory loss. Market expansion is fueled by increasing R and D efforts and product innovation. Due to today’s hurried lifestyle and mental stress, a brain health supplement is an excellent lifestyle product. People of all ages, whether working or retired, can take brain health supplements or boosters all around the globe.
Some major players in the market include AlternaScript, LLC, Cephalon, Inc., Hunan Jianlang Pharmaceutical Co., Ltd, Luna Chemicals Co., Ltd, Peak Nootropics, and Xintai Pharmaceutical Co., Ltd., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers and acquisitions, geographical expansion, partnerships, collaborations, and new product launches, to stay competitive in the market.
Peak Nootropics offers Brain AntiOxidant Stack, L-theanine contains anti-anxiety and anti-learning properties. Oxiracetam improves memory and concentration while also improving overall well-being. Choline l-bitartrate has been proven to have antioxidant effects on neurons in addition to being an acetylcholine source, and to be particularly effective when combined with the neuroprotective properties of Acetyl L-Carnitine (ALCAR). These natural nootropics work together to create a powerful antioxidant brain stack.

Market Coverage
The market number available for – 2021-2028
Base year- 2021
Forecast period- 2022-2028

Segment Covered-
By Product Type
By Application

Regions Covered-
North America
Europe
Asia-Pacific
Rest of the World

 

Top major key player
AlternaScript, LLC, Cephalon, Inc., Hunan Jianlang Pharmaceutical Co., Ltd, Luna Chemicals Co., Ltd, Peak Nootropics, Xintai Pharmaceutical Co., Ltd., among others.

Key questions addressed by the report
What is the market growth rate?
Which segment and region dominate the market in the base year?
Which segment and region will project the fastest growth in the market?
How has COVID-19 impacted the market?
Deviation from the pre-COVID-19 forecast
Most affected region and segment
Who is the leader in the market?
How players are addressing challenges to sustain growth?
Where is the investment opportunity?

Global Oxiracetam Market Report by Segment
By Product Type
Powder
Capsule

By End-User
Alzheimer’s Disease
Dementia
Other